First ‘Artificial Meniscus’ Wins FDA Breakthrough Device Designation
Birnam Wood Capital, LLC — Sep 22, 2019
©2024. All rights reserved. Securities are offered through and held in custody at TD Ameritrade, Inc., member FINRA/SIPC/NFA. Advisory services are offered through Birnam Wood Capital, LLC, a state Registered Investment Advisor firm registered in the State of Texas. No information provided in this site is intended to constitute an offer to sell or a solicitation of an offer to buy shares of any security, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer, solicitation, purchase or sale would be unlawful under securities laws of such jurisdiction.